DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 133 filers reported holding DIPLOMAT PHARMACY INC in Q2 2019. The put-call ratio across all filers is 2.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $300,000 | +971.4% | 75,000 | +1174.2% | 0.00% | – |
Q3 2019 | $28,000 | -90.0% | 5,886 | -87.3% | 0.00% | -100.0% |
Q2 2019 | $281,000 | +83.7% | 46,233 | +75.5% | 0.00% | – |
Q1 2019 | $153,000 | -77.9% | 26,340 | -26.2% | 0.00% | -100.0% |
Q3 2018 | $693,000 | +231.6% | 35,711 | +244.3% | 0.00% | -77.8% |
Q1 2018 | $209,000 | -27.4% | 10,373 | -27.9% | 0.01% | -25.0% |
Q4 2017 | $288,000 | +476.0% | 14,387 | +354.4% | 0.01% | +500.0% |
Q1 2017 | $50,000 | +4900.0% | 3,166 | +2298.5% | 0.00% | – |
Q4 2016 | $1,000 | -97.6% | 132 | -91.2% | 0.00% | -100.0% |
Q3 2016 | $42,000 | -76.3% | 1,503 | -76.8% | 0.00% | -78.6% |
Q1 2016 | $177,000 | -66.5% | 6,473 | -58.1% | 0.01% | -65.9% |
Q4 2015 | $528,000 | +1408.6% | 15,443 | +1160.7% | 0.04% | +1266.7% |
Q3 2015 | $35,000 | -52.1% | 1,225 | -25.4% | 0.00% | -50.0% |
Q2 2015 | $73,000 | – | 1,642 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |